Lv11
80 积分 2024-07-29 加入
Enfortumab Vedotin and Pembrolizumab — A New Perspective on Urothelial Cancer
2个月前
已完结
Enhancing the Pharmacokinetics and Antitumor Activity of an α-Amanitin-Based Small-Molecule Drug Conjugate via Conjugation with an Fc Domain
2个月前
已完结
Unlocking the mechanisms underlying the activity of pembrolizumab plus enfortumab vedotin in patients with urothelial carcinoma
2个月前
已完结
Design of a Small-Molecule Drug Conjugate for Prostate Cancer Targeted Theranostics
2个月前
已完结
Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes
6个月前
已完结
Molecular subtypes as potential biomarkers in renal cell carcinoma
6个月前
已完结
Microbiome subsets determine tumor prognosis and molecular characteristics of clear-cell renal cell carcinoma: a multi-center integrated analysis of microbiome, metabolome, and transcriptome data
6个月前
已完结
Single-cell analyses highlight the proinflammatory contribution of C1q-high monocytes to Behçet’s disease
8个月前
已完结
Chronic kidney disease in inflammatory bowel disease, a systematic review and meta-analysis
9个月前
已完结
Glomerulonephritis and inflammatory bowel disease: A tale of gut-kidney axis dysfunction
9个月前
已完结
皖公网安备34019202002308
